Dr. Adam Bagg, MD
Pathology (Clinical Pathology/Laboratory Medicine Physician)
- Medicare participating
At a glance
- Years since graduation
- 45
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 28
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Clinical Pathology/Laboratory Medicine Physician primary
PA license MD068350L -
Anatomic Pathology & Clinical Pathology Physician
PA license MD068350L -
Hematology (Pathology) Physician
PA license MD068350L
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- University of Penn - Medical Group (3,505 clinicians)
- Wills Eye Ophthalmology Clinic, Inc (147 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 28
- Services billed
- 263
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Special stained specimen slides to examine tissue including interpretation and report | 772 | 125 |
| Special stained specimen slides to examine tissue, each additional procedure | 706 | 80 |
| Flow cytometry technique for dna or cell analysis, 9 to 15 markers | 305 | 252 |
| Pathology examination of tissue using a microscope, intermediate complexity | 296 | 153 |
| Preparation of tissue for examination by removing any calcium present | 133 | 124 |
| Bone marrow, smear interpretation | 129 | 120 |
| Microscopic genetic analysis of tumor, manual | 128 | 106 |
| Special stained specimen slides to examine tissue, initial procedure | 109 | 98 |
| Blood smear interpretation by physician with written report | 34 | 32 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 34 | 33 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 1 companies reported 2 payments worth $5,356 in total to this clinician.
| Recordati_rare_diseases_inc. | $5,356 |
|---|
| Honoraria | $5,356 |
|---|
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Recordati_rare_diseases_inc. Oct 10, 2025 | Honoraria SYLVANT · ONCOLOGIC AGENT | $3,863 |
| Recordati_rare_diseases_inc. Apr 15, 2025 | Honoraria SYLVANT · ONCOLOGIC AGENT | $1,494 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.